Views & Analysis Pre-exposure treatment to help prevent HIV Wider use of Pre-Exposure Prophylaxis (PrEP), where people who don't have HIV take a pill every day, could prevent around 7,400 new HIV infections in the UK by 2020.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
